NCT05787236View on ClinicalTrials.gov

A Study of Moderate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world Setting

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

March 15, 2022

Study Completion Date

March 15, 2022

Conditions
Moderate-to-severe Plaque Psoriasis
Trial Locations (1)

Unknown

Mangga Besar Clinic, Jakarta

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY